The claims analysis of over 200,000 adults with type 2 diabetes found a 6% lower MACE risk, though doctors note it shows association, not cause, and adherence may play a role.
Recap by typeshit. Full story at Healthline.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Two ASPS member surgeons walk through the breast changes patients may notice after losing weight on GLP-1 drugs, and what to know about them.
Monash dermatologist Greg Goodman likens the gaunt, looser look some people get after rapid GLP-1 weight loss to "ageing on steroids."
Loading…